Ependymomas

Also known as: Ependymoma

DrugDrug NameDrug Description
DB00262CarmustineA cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
DrugDrug NamePhaseStatusCount
DB00853Temozolomide0Withdrawn1
DB00531Cyclophosphamide1Recruiting2
DB00260Cycloserine1Completed1
DB00773Etoposide1Recruiting1
DB00099Filgrastim1Recruiting1
DB00544Fluorouracil1Completed1
DB00441Gemcitabine1Recruiting1
DB00724Imiquimod1Completed1
DB12827Indoximod1Recruiting1
DB00019Pegfilgrastim1Recruiting1
DB11730Ribociclib1Recruiting1
DB00877Sirolimus1Active Not Recruiting1
DB09143Sonidegib1Recruiting1
DB00853Temozolomide1Completed1
DB00853Temozolomide1Recruiting1
DB08911Trametinib1Recruiting1
DB07232Veliparib1Completed1
DB06400Vitespen1Recruiting1
DB00112Bevacizumab2Recruiting1
DB00958Carboplatin2Recruiting1
DB00958Carboplatin2Terminated1
DB00530Erlotinib2Recruiting1
DB00530Erlotinib2Terminated1
DB09150Fludeoxyglucose F-182Recruiting1
DB05036Grn163l2Terminated1
DB01043Memantine2Recruiting1
DB00134Methionine2Recruiting1
DB09035Nivolumab2Recruiting1
DB00642Pemetrexed2Completed1
DB11689Selumetinib2Recruiting1
DB00853Temozolomide2Recruiting1
DB08881Vemurafenib2Recruiting1
DB00958Carboplatin2 / 3Completed1
DB00773Etoposide2 / 3Completed1
DB00853Temozolomide2 / 3Completed1
DB04572Thiotepa2 / 3Completed1
DB12902Trofosfamide2 / 3Completed1
DB00724ImiquimodNot AvailableRecruiting1